A White House deal with Eli Lilly & Co. and Novo Nordisk to lower the prices of their popular obesity medicines, Zepbound and Wegovy, is a step toward making them more affordable and accessible ...

While weight loss drugs have helped people shed several pounds, some have also reported excess hair fall. A Delhi-based dermatologist recommended what you should do, including natural supplements, red ...

Hampton followed up with a thought about the Treat and Reduce Obesity Act (TROA) — a bipartisan bill in the U.S. Congress ...

Medicare will cover GLP-1 weight loss drugs for specific patient groups, beginning in mid-2026, under a deal struck with drugmakers.

After writing dozens of GLP-1 articles over the past year, one issue that consistently comes up is the affordability of ...

Oral GLP-1 weight loss pills could replace injections by March 2026 at $150 monthly, Medicare chief Dr. Mehmet Oz predicted in a FOX Business appearance.

After [losing out to Pfizer]( ...

New versions of drugs like Wegovy, Ozempic, Mounjaro and Zepbound, including pills, will be easier to take, more effective ...

A Trump administration deal to slash prices on blockbuster weight-loss drugs such as Wegovy and Zepbound is expected to make ...

President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce ...

Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war ...

The deal comes as Phizer is attempting to develop its own stake in that market, several months after ending development of a potential pill treatment for obesity.In a statement issued Friday, Metsera ...